Wednesday, November 11, 2026

Mounjaro can be bought in Japan and brought back ... Obesity drugs purchased overseas can be brought into Korea

Input
2026-11-11 17:52:30
Updated
2026-11-11 17:52:30
GLP-1 obesity drug Mounjaro. Yonhap News Agency
[Financial News] Procedures for bringing obesity drugs such as Wegovy and Mounjaro, purchased overseas, into Korea will be simplified. Starting on the 12th, medicines purchased with a valid prescription may be carried into the country in quantities of up to six bottles; even if that limit is exceeded, up to a three-month supply will be allowed.
The Ministry of Food and Drug Safety said on the 11th that, following consultations with the Korea Customs Service, it had decided to allow people to carry in medicines for personal treatment.
The measure follows continued cases in which medicines properly prescribed and purchased overseas were held up at customs when people entered Korea. In particular, as demand has grown for bringing obesity drugs such as Wegovy and Mounjaro—prescribed or purchased overseas—into Korea, the need to clarify the relevant standards has been raised.
Under the new standards, medicines purchased with a valid prescription in Korea or abroad may be carried in up to six bottles, provided they are products approved by the relevant drug regulatory authorities in each country. Even when carrying more than six bottles, travelers may bring in up to a three-month supply, taking into account each medicine’s directions for use and dosing interval.
Under the revised standards, up to 12 units of GLP-1 obesity drugs administered once a week—equivalent to a three-month supply—may be brought into Korea.
The rules apply not only to medicines purchased overseas but also to medicines people were already taking, took abroad, and then bring back into Korea. They also apply when foreign nationals or international students bring into Korea medicines they had been taking overseas, and when travelers carry home medicines prescribed or purchased during a trip abroad.
The Ministry of Food and Drug Safety expects the measure to reduce the inconvenience involved in bringing into Korea medicines for personal treatment that were properly prescribed overseas.

[email protected] Jung Sang-hee Reporter